"10.1371_journal.pone.0053733","plos one","2013-01-10T00:00:00Z","Fernando Lopez-Rios; Barbara Angulo; Belen Gomez; Debbie Mair; Rebeca Martinez; Esther Conde; Felice Shieh; Jeffrey Vaks; Rachel Langland; H Jeffrey Lawrence; David Gonzalez de Castro","Laboratorio de Dianas Terap√©uticas, Hospital Universitario Sanchinarro, Madrid, Spain; The Royal Marsden NHS Trust and The Institute of Cancer Research, Sutton, London, United Kingdom; Roche Molecular Systems, Pleasanton, California, United States of America","Conceived and designed the experiments: FLR DGdC HJL FS. Performed the experiments: BA RM BG DM JV EC RL. Analyzed the data: FLR DGdC HJL FS BA RM BG DM EC JV RL. Wrote the paper: FLR DGdC HJL FS BA RM BG DM EC JV RL.","FS, JV, and RL are employees of Roche Molecular Systems, the funder of this study. HJL is a former employee of Roche Molecular Systems. DGdC declares the receipt of honoraria from Roche Molecular Systems (Pleasanton, CA) and Roche Products Ltd (UK). FLR declares the receipt of honoraria from Roche Molecular Systems (Pleasanton, CA) and Roche Diagnostics (Spain). Miller Medical was contracted by Roche Molecular Systems and contributed in the drafting of this manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","01","Fernando Lopez-Rios","FLR",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
